Mora J Rodrigo, von Andrian Ulrich H
CBR Institute for Biomedical Research & Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Trends Immunol. 2006 May;27(5):235-43. doi: 10.1016/j.it.2006.03.007. Epub 2006 Mar 31.
Naive and effector/memory T cells have distinct repertoires of trafficking ligands and receptors that restrict their ability to interact with specialized microvessels in different anatomical compartments and, consequently, have distinct patterns of migration. Antigen-experienced lymphocytes can be further subdivided into different subsets based on their expression of characteristic sets of trafficking receptors that favor their accumulation in certain target organs, including the skin and gut. Here, we summarize recent advances that have broadened our understanding of the cellular and molecular events that induce the generation of tissue-specific effector/memory T cells and discuss how these mechanisms could be harnessed for the therapeutic manipulation of T-cell-dependent pathologies.
初始T细胞和效应/记忆T细胞具有不同的归巢配体和受体库,这些配体和受体限制了它们与不同解剖区域中特化微血管相互作用的能力,因此具有不同的迁移模式。基于抗原的淋巴细胞可根据其归巢受体特征集的表达进一步细分为不同亚群,这些受体有利于它们在某些靶器官(包括皮肤和肠道)中积累。在此,我们总结了近期的进展,这些进展拓宽了我们对诱导组织特异性效应/记忆T细胞产生的细胞和分子事件的理解,并讨论了如何利用这些机制对T细胞依赖性疾病进行治疗性调控。